Other languages Palisade Bio, Inc.

Equities

SNCA

US6963894026

Real-time Estimate Cboe BZX Other stock markets 07:16:33 02/05/2024 pm IST			5-day change	1st Jan Change
7.1 ^USD	+0.28%		+6.21%	-25.23%

01/05	Wall Street Set to Open Lower Ahead of Fed Rate Decision; Private Employment Figures Top Forecasts	MT
01/05	Palisade Bio?s Lead Product Candidate, PALI-2108 Demonstrates Potent Anti-Inflammatory Effects in Ex-Vivo Study of Whole Blood Samples Challenged with Pro-Inflammatory Lipopolysaccharide	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Wall Street Set to Open Lower Ahead of Fed Rate Decision; Private Employment Figures Top Forecasts	01/05
Palisade Bio?s Lead Product Candidate, PALI-2108 Demonstrates Potent Anti-Inflammatory Effects in Ex-Vivo Study of Whole Blood Samples Challenged with Pro-Inflammatory Lipopolysaccharide	01/05
Palisade Bio, Inc. Enters into Strategic Collaboration with Strand Life Sciences to Advance Precision Medicine Approach	23/04
Palisade Bio Successfully Demonstrates Bioactivation of PALI-2108 In Ex-Vivo Study of Normal Healthy and Ulcerative Colitis Patients? Stool	16/04
Palisade Bio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	27/03
Palisade Bio, Inc. Announces Resignation of Mary Ann Gray as Member of the Board	07/03
Palisade Bio Names Donald Williams as Chairman	13/02
Palisade Bio, Inc. Announces Advisory Board Appointments	09/02
MÄRKTE USA/Fester - Neue Rekordhochs dank sinkender Anleihezinsen	30/01
Sector Update: Health Care Stocks Stronger Late Afternoon	30/01
Sector Update: Health Care Stocks Advance Monday Afternoon	30/01
Top Midday Gainers	30/01
Palisade Bio's Shares Climb Following Preclinical Data on Ulcerative Colitis Drug Candidate	29/01
LATE BRIEFING - Unternehmen und Märkte	29/01
MÄRKTE USA/Kaum verändert - Vor Fed-Entscheid dominiert Zurückhaltung	29/01
MÄRKTE USA/Wall Street startet wenig verändert in Fed-Woche	29/01
MÄRKTE USA/Wall Street wenig verändert erwartet	29/01
MORNING BRIEFING - USA/Asien	29/01
Palisade Bio Says Giiant Pharma Receives Second Milestone Payment for PALI-2108 Development	28/12
Palisade Bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	10/11

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Palisade Bio, Inc.

Equities

SNCA

US6963894026

Other languages

Filters